Pharmacological Studies of Novel Marine Metabolites
Fundamental to the complex process associated with drug discovery is the establishment of a carefully defined collaborative relationship between academic bioorganic chemists and cellular or molecular pharmacologists. We mention this as a new emerging direction in research that should be particularly emphasized in an academic setting. The collaborative goal of the academic chemists and pharmacologists should be to contribute in some specific way to the advancement of each other’s science. Educational goals are not served well through routine programs for isolating and screening natural products. Screening programs of this kind are well developed in U.S. and foreign drug companies. In fact, new molecular receptor assays that allow a wide variety and large number of screens to be executed rapidly are becoming available. Academic pharmacologists have the responsibility to develop knowledge fundamental to advancing biomedical science by using bioactive substances as probes to better understand normal and pathological biological processes, to define in rigorous fashion the properties of these probes, and to determine their biochemical limitations and how they can be used properly and safely.
KeywordsOncol Doxorubicin Cytosol Myeloma Bark
Unable to display preview. Download preview PDF.
- Bellamy, W. T, Dalton, W. S., Kailey, J. M., Gleason, M. C., McCloskey, T. M., Dorr, R. T, and Alberts, D. S., 1988, Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage, Cancer Res. 48 (22): 6365–6370.PubMedGoogle Scholar
- Biedler, J. L., and Meyers, M. B., 1989, Multidrug resistance (vinca alkaloids, actinomycin D, and anthracycline antibiotics), Drug Resist. Mamm. Cell 2: 57–58.Google Scholar
- Bonney, R. J., Wightman, P. D., Dahlgren, M. E., Davies, P., Kuehl, F. A., and Humes, J., 1980, Effect of RNA and protein synthesis inhibitors on the release of inflammatory mediators by macrophages responding to phorbol myristate acetate, Biochim. Biophys. Acta 633: 410–421.PubMedCrossRefGoogle Scholar
- Cimino, G., De Stefano, S., and Minale, L., 1974, Scalaradial, a third sesterterpene with the tetracarbocyclic skeleton of scalarin, from the sponge Cacospongia mollior, Experientia 30: 846–847.Google Scholar
- De Freitas, J. C., Blankemeier, L. A., and Jacobs, R. S., 1984, In vitro inactivation of the neurotoxic action of 3-bungarotoxin by the marine natural product, manoalide, Experientia 40(7):864–865.Google Scholar
- Fox, G. W., Kriebel, M. E., and Pappas, G. D., 1990, Morphological, physiological and biochemical observation on skate electric organ, Anat. Embryol. 18: 305–315.Google Scholar
- Goodman Gilman, A., Goodman, S. S., Rall, W. T., and Murad, F., 1985, The Pharmacological Basis of Therapeutics, 7th ed., Macmillan, New York.Google Scholar
- Hermanowicz, A., Gibson, P. R., and Jewell, D. P., 1985, The role of phagocytes in inflammatory bowel disease, Clin. Sci. 69: 2241–2249.Google Scholar
- Lewis, R. A., and Austen, K. F.,1984, The biologically active leukotrienes: Biosynthesis, metabolism, receptors, functions, and pharmacology, J. Clin. Invest. 73: 889–897.Google Scholar
- O’Brien, E. T., Asai, D. J., Groweiss, A., Lipshutz, B. H., Fenical, W, Jacobs, R. S., and Wilson, L., 1986, Mechanism of action of the marine natural product stypoldione: Evidence for reaction with sulfhydryl groups, J. Med. Chem. 29: 1829–1851.Google Scholar
- Schwartzman, M. L., Balazy, M., Masferrer, J., Abraham, N. G., McGiff, J. C., and Murphy, R. C., 1987, 12 (R)-hydroxyicosatetraenoic acid: A cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea, Proc. Natl. Acad. Sci. USA 84: 8125–8129.Google Scholar
- Staats, J., Marquardt, D., and Center, M. S., 1990, Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates p-glycoprotein, J. Biol. Chem. 265: 4084 4090.Google Scholar